1 completed. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow regdanvimab: new trials by email Literature Review of regdanvimab trials Research Report on regdanvimab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 2/3 Study to Evaluate the Efficacy and Safety of CT-P59 in Patients With Mild to Moderate SARS-CoV-2 Infection CT-P59, Placebo - SARS-CoV-2 Infection | Phase 2 / Phase 3 | Completed | Celltrion | 1642 | 2020-10-05 | 2022-07-20 |
COVID-19 (1)
Celltrion (1)
South Korea (1)